tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Lyra Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsLyra Therapeutics Reports Q2 2025 Financial Results
2M ago
Lyra Therapeutics reports Q2 EPS ($5.51), consensus ($4.78)
Premium
The Fly
Lyra Therapeutics reports Q2 EPS ($5.51), consensus ($4.78)
2M ago
Is LYRA a Buy, Before Earnings?
Premium
Pre-Earnings
Is LYRA a Buy, Before Earnings?
2M ago
Lyra Therapeutics target adjusted to $16 from $2 at H.C. Wainwright
PremiumThe FlyLyra Therapeutics target adjusted to $16 from $2 at H.C. Wainwright
4M ago
Lyra Therapeutics Unveils Strategic Plans for LYR-210
Premium
Company Announcements
Lyra Therapeutics Unveils Strategic Plans for LYR-210
4M ago
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories
Premium
Market News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories
4M ago
Upcoming Stock Splits This Week (May 27 to May 30) – Stay Invested
PremiumMarket NewsUpcoming Stock Splits This Week (May 27 to May 30) – Stay Invested
5M ago
Lyra Therapeutics Announces Reverse Stock Split Decision
Premium
Company Announcements
Lyra Therapeutics Announces Reverse Stock Split Decision
5M ago
Lyra Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Lyra Therapeutics Reports Q1 2025 Financial Results
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100